Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - disopyramide 150mg (as base) - capsule - 150 mg - active: disopyramide 150mg (as base) excipient: gelatin magnesium stearate maize starch purified talc starch titanium dioxide

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

carsl consulting - quetiapine fumarate 172.69mg equivalent 150 mg quetiapine;   - film coated tablet - 150 mg - active: quetiapine fumarate 172.69mg equivalent 150 mg quetiapine   excipient: calcium hydrogen phosphate dihydrate hypromellose iron oxide yellow lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate titanium dioxide

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg; erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg; erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg; erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg - film coated tablet - 150 mg - active: erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opacode brown s-8-26595 opadry white y-5-7068 sodium laurilsulfate sodium starch glycolate active: erlotinib hydrochloride 163.93mg equivalent to erlotinib 150 mg excipient: hyprolose hypromellose lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose opadry white y-5-7068 sodium laurilsulfate sodium starch glycolate titanium dioxide - · tarceva is indicated for the first-line and maintenance treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. · tarceva is also indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer (nsclc) who have previously received chemotherapy.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - nilotinib hydrochloride monohydrate 165.45mg equivalent to 150 mg nilotinib anhydrous free base;  ;   - capsule - 150 mg - active: nilotinib hydrochloride monohydrate 165.45mg equivalent to 150 mg nilotinib anhydrous free base     excipient: colloidal silicon dioxide crospovidone gelatin iron oxide red iron oxide yellow lactose monohydrate magnesium stearate opacode ink black s-1-277002 poloxamer 188 titanium dioxide - tasigna is indicated for the: · treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase, · treatment of chronic phase and accelerated phase philadelphia chromosome positive chronic myelogenous leukaemia (cml) in adult patients resistant to or intolerant to at least one prior therapy including imatinib.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - tramadol hydrochloride 150mg - modified release tablet - 150 mg - active: tramadol hydrochloride 150mg excipient: colloidal silicon dioxide hypromellose   iron oxide red lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose propylene glycol purified talc quinoline yellow titanium dioxide - relief of moderate to severe pain.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 150mg;  ;  ;   - film coated tablet - 150 mg - active: oxcarbazepine 150mg       excipient: colloidal silicon dioxide crospovidone hypromellose   iron oxide black iron oxide red iron oxide yellow macrogol 4000 magnesium stearate powdered cellulose purified talc titanium dioxide - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - lacosamide 150mg;  ;   - film coated tablet - 150 mg - active: lacosamide 150mg     excipient: colloidal silicon dioxide crospovidone hyprolose   magnesium stearate microcrystalline cellulose opadry tan 85f27043 - monotherapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. add-on therapy in the treatment of partial seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - capecitabine 150mg;   - film coated tablet - 150 mg - active: capecitabine 150mg   excipient: croscarmellose sodium hypromellose lactose magnesium stearate microcrystalline cellulose opadry pink 03a14309 - xeloda is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated. xeloda in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - omalizumab 150mg - powder for injection with diluent - 150 mg - active: omalizumab 150mg excipient: histidine histidine hydrochloride polysorbate 20 sucrose water for injection - xolair is indicated for the reduction of asthma exacerbations and control of asthma symptoms when given as add-on therapy for adult and adolescent patients, 6 years and older, with severe persistent allergic asthma who have ige > 30 iu/ml, a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled iwth inhaled corticosteroids.

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - bupropion hydrochloride 150mg;   - modified release tablet - 150 mg - active: bupropion hydrochloride 150mg   excipient: carnauba wax cysteine hydrochloride monohydrate hypromellose magnesium stearate opacode black ns-78-17821 opadry white oy-7300 powdered cellulose - the treatment of nicotine dependence as an aid to smoking cessation.